NCT06650579
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial No drug interventions treatment 3 not_yet_recruiting NCT06630325
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced, Recurrent Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer treatment 2 not_yet_recruiting NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV treatment 1 active_not_recruiting NCT05779943
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer diagnostic 2 active_not_recruiting NCT02099864
Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy treatment 2 active_not_recruiting NCT02985021
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies treatment 2 terminated NCT04857502
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer No drug interventions basic_science 0 recruiting NCT04519879
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA No drug interventions treatment 2 recruiting NCT01638533
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction treatment 1 active_not_recruiting NCT02673151
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment diagnostic 2 / 3 completed NCT03902951
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer treatment 2 active_not_recruiting NCT02935205
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer treatment 1 / 2 recruiting NCT01251861
Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer treatment 2 active_not_recruiting NCT05722288
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers No drug interventions supportive_care 2 recruiting NCT00108732
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer treatment 2 completed NCT04457232
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation No drug interventions basic_science 1 active_not_recruiting NCT02420652
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy treatment 2 terminated NCT00936975
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases No drug interventions diagnostic 2 completed NCT03698370
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer No drug interventions diagnostic 2 completed NCT01120236
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer treatment 2 completed NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT02499835
Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer treatment 1 / 2 completed NCT00170157
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer treatment 2 completed NCT02312557
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide treatment 2 active_not_recruiting NCT02228265
Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide Not Available Not Available completed NCT03582774
Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy No drug interventions diagnostic 3 active_not_recruiting NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT00064129
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer treatment 1 completed NCT03501940
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer No drug interventions Not Available Not Available no_longer_available NCT03796767
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer No drug interventions treatment 2 active_not_recruiting NCT01050504
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer No drug interventions Not Available Not Available recruiting NCT01576172
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer treatment 2 completed NCT01519414
Tivantinib in Treating Patients With Metastatic Prostate Cancer treatment 2 completed NCT01145508
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 terminated NCT03122743
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer No drug interventions Not Available Not Available completed NCT02899221
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation No drug interventions treatment Not Available active_not_recruiting NCT03515577
Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery diagnostic 2 completed NCT02807805
Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer treatment 2 active_not_recruiting NCT03123978
Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer treatment 1 completed NCT02522715
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer treatment 1 / 2 active_not_recruiting NCT02488070
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer diagnostic 1 / 2 completed NCT02881242
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer treatment 2 active_not_recruiting NCT00486642
Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy treatment 2 completed NCT01253642
Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel treatment 2 terminated NCT03016741
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer supportive_care 4 unknown_status NCT02206334
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer No drug interventions treatment 1 completed NCT01786265
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer treatment 2 active_not_recruiting NCT01787331
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer treatment 2 completed NCT05238831
SMMART Adaptive Clinical Treatment (ACT) Trial treatment 0 withdrawn NCT00536991
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer treatment 1 / 2 terminated NCT05034562
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer diagnostic 2 withdrawn NCT02940262
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy No drug interventions diagnostic 3 completed NCT01503229
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 completed NCT01953640
Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy No drug interventions Not Available Not Available active_not_recruiting NCT04190446
Radiation Therapy (Hypofractionated Proton Beam Therapy or IMRT) for the Treatment of Recurrent, Oligometastatic Prostate Cancer Following Primary Localized Treatment No drug interventions treatment 2 active_not_recruiting NCT02532114
Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer treatment 1 completed NCT02601014
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 treatment 2 completed NCT02159950
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer treatment 2 completed NCT01026623
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer treatment 1 / 2 completed NCT01833208
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T No drug interventions treatment Not Available completed